American Society of Hematology

Newsroom

ASH, the world's largest professional society concerned with the causes and treatments of blood disorders, regularly issues press releases highlighting clinical and research advances announced at the ASH annual meeting and published in Blood, as well as releases and statements on breaking policy news affecting the field of hematology.

Need to speak with an expert? Complete our Request An Expert form.

To be added to ASH's press release distribution list, contact Sara Khalaf at skhalaf@hematology.org.

Latest Press Releases

  • New study finds cellular immunotherapy treatment associated with improved quality of life Feb 19, 2020

    Adult lymphoma patients whose disease was effectively treated with chimeric antigen receptor T-cell (CAR-T) therapy showed marked improvement on a variety of self-reported quality of life measures, according to a study published today in Blood Advances. The study offers evidence that CAR-T may not only extend cancer patients’ survival, but also improve their quality of life after treatment.

  • Statement on New ASH Clinical Practice Guidelines on Sickle Cell Disease-Related Transfusion Support Jan 27, 2020

    Today, the American Society of Hematology (ASH) released new clinical practice guidelines on Sickle Cell Disease (SCD)-Related Transfusion Support. These guidelines are part of a series of five guidelines ASH is developing on SCD to provide updated treatment guidelines that reflect the newest evidence about the disease, ensuring the medical community can better treat SCD and people with SCD can make the best decisions for their care.

  • Minority Hematology Scholars to Study New Methods for Improving Blood Disease Treatments Jan 23, 2020

    The American Society of Hematology is pleased to announce that Gabriela Hobbs, MD, of Massachusetts General Hospital, and Oluwatoyosi Onwuemene, MD, MS, of Duke University have been selected to participate in the American Society of Hematology-Harold Amos Medical Faculty Development Program, a partnership between ASH and the Robert Wood Johnson Foundation.

View all